BRISTOL MYERS SQUIBB

Tracey Marantal joins Worldwide Clinical Trials as President of the Oncology Business Unit, bringing over 20 years of clinical operations and oncology expertise to lead the CRO's oncology portfolio, which has seen accelerated growth amid rapid advances in cancer research.

Clinical trials historically underrepresented women, especially women of color, in cardiovascular research. Dr. Roxana Mehran discusses the Librexia program. For more info on cardiovascular and stroke trials, visit ResearchIncludesMe.com.

FDA may approve KarXT, a novel antipsychotic for schizophrenia, potentially the first new treatment in 70 years. KarXT combines xanomeline and trospium to target brain receptors, reducing acute psychotic symptoms with fewer side effects. However, concerns include potential cardiovascular risks, unclear long-term efficacy, and high cost.

Tracey Marantal joins Worldwide Clinical Trials as President of the Oncology Business Unit, bringing over 20 years of clinical operations experience, including 15 years in oncology. Her expertise in precision oncology and complex trial designs will enhance Worldwide's oncology portfolio, driving innovation in cancer treatment.

VerImmune Inc. secures $4.5 million in Pre-Series A funding led by Beiley Biofund, with participation from Dr. John Ballantyne and others. The funds will advance the ViP-based therapeutics platform, including the lead product VERI-101, a first-in-class cancer immunotherapy. The company also adds Dr. Che Hsu and Dr. Marta New to its Board of Directors.

S.K., D.A.M., J.P., H.S., X.Z., P.H., T.X., and H.S. have financial ties to various pharmaceutical companies, including stock ownership and advisory roles. F.C., J.D., E.V.C., H.S.W., T.Y., R.Y., and J.T. also report consulting or advisory roles and research funding from multiple institutions and companies.

Senator Bernie Sanders will lead a Senate HELP Committee hearing on Ozempic and Wegovy prices, focusing on price controls despite R&D costs and potential harm to medical innovation. The hearing aims to address the high cost of these diabetes medicines, but critics argue it overlooks the significant R&D investments required and the broader implications for future drug development.

VerImmune Inc. secures $4.5 million in Pre-Series A funding led by Beiley Biofund. The company plans to advance its ViP-based therapeutics, including the lead product VERI-101, a cancer immunotherapy. New board members Dr. Che Hsu and Dr. Marta New bring extensive experience in novel modalities.

Prime Minister Narendra Modi held a roundtable with tech CEOs in New York to boost India-US cooperation in AI, Quantum Computing, Biotechnology, Life Sciences, IT, and Semiconductors. Modi emphasized India's potential as a global tech hub, inviting companies to co-develop, co-design, and co-produce in India. CEOs expressed interest in expanding investments and collaborations, highlighting India's innovation-friendly policies and rapid digital expansion.

Over 1 billion people worldwide live with obesity, a global health crisis affecting all income levels. Treatments include lifestyle modification, pharmacotherapies, and bariatric surgery, but implementation gaps exist. Multidisciplinary approaches and patient-centricity are crucial for effective management and clinical trials, addressing social determinants of health and diverse patient needs.